Agenda for Day One - Tuesday November 17, 2026 - EST
This session opens with a look at the macro forces reshaping the industry and how leading life sciences organizations are responding. We'll then take you inside Anaplan's new GTN application, purpose-built with industry best practices, faster to implement, and designed to lower total cost of ownership. A live demo will show how Anaplan's AI capabilities surface insights in moments rather than days.
Key highlights include:
- What's changed in the GTN landscape over the past year, and where the market is heading
- A live demo of Anaplan's new GTN application, including customer-level forecasting across rebates, chargebacks, distributor agreements, and government price types
- How Anaplan AI accelerates scenario analysis, variance explanation, and forecast insight
- Why GTN is the ideal launching point for transformation, and how mature customers extend into connected pre-deal, post-deal, demand, and financial planning
Walk away with a clear picture of what's possible today and a roadmap for turning GTN into the catalyst for enterprise-wide change.
- Scott DeKoster - RVP, Life Sciences, Anaplan
- Nicholai Anderson-Peña - Solutions Consulting, Life Sciences, Anaplan
- Tara Rockers - GM Strategy, Life Sciences, Anaplan
- Prakash Chainani - Senior Vice President – Finance, HR and IT, Lifestar Pharma LLC (a Mankind Group Company)
- Master the art of translating complex GTN analytics and AI-driven insights into compelling narratives that resonate with executive leadership and cross-functional stakeholders
- Develop advanced presentation strategies that transform dense financial data and technical concepts into clear, actionable business intelligence that drives strategic decision-making
- Build frameworks for presenting GTN provisions and accruals to audit committees, including documentation of significant estimates, revenue recognition judgments under ASC 606 and internal control effectiveness for SOX compliance
CPE Credits Available: 1.2
- Jenisha Malhotra - Senior Manager, Deloitte & Touche LLP
- Michael Kirk - Senior Manager, Deloitte & Touche LLP
- IRA implementation, financial implications, and strategies to adapt
- MFP program implementation: accounting treatment, revenue recognition adjustments, quarterly close processes, reconciliation methodologies, and audit documentation requirements
- Medicare Part D redesign
- Medicaid best price considerations
- MFN updates
- CMS international reference pricing initiatives (GENEROUS/GUARD/GLOBE)
- 340B reform impacts
- Impact of tariffs
- Examine net revenue implications through real-world case studies demonstrating the financial impact of key policy and regulatory updates
CPE Credits Available: 1.2
- Walt Worsham - Managing Director, IntegriChain
- Master price protection mechanisms and contractual triggers across commercial plans, Medicaid (best price, URA), Medicare (Part D, coverage gap), and institutional channels (GPOs, 340B), with practical frameworks for managing obligations and minimizing revenue risk
- Implement advanced GTN accrual methodologies and revenue recognition strategies for forecasting price protection liabilities, modeling inflation adjustments and regulatory price increases, while maintaining ASC 606 compliance
- Build financial controls for tracking and validating claims across payer types, ensuring provision accuracy, streamlining true-up processes and resolving cross-channel conflicts
- Develop audit-ready documentation practices and compliance strategies for price protection calculations across payer channels, ensuring defensible assumptions and regulatory preparedness
CPE Credits Available: 1.2
- Hilary Sherman - Independent, Independent
- Darpan Jhaveri - Senior Director - US Revenue and Inventory Accounting, Insmed Incorporated
- Felecia Manning - Senior Director, Pricing and Government Programs, Market Access, United Therapeutics Corporation
- Jennifer English - Value & Access Chief of Staff, Head of US Price & Value Optimization, Ipsen
This session demonstrates how modern reporting and analytics transform complex data into actionable intelligence. Leveraging interactive dashboards, trend and anomaly detection, transaction drilldown, and AI-powered insights, organizations can gain deeper visibility into business performance, identify opportunities and risks more quickly, and make confident decisions backed by data.
- Josh Gingerich - Chief Customer Success Officer, Kernel
- Marcus Bourget - Customer Success Officer, Kernel
- Master early-stage asset and launch brand forecasting with proven frameworks for building defensible assumptions and managing stakeholder expectations across uncertain market conditions
- Develop flexible scenario planning and stress-testing capabilities to rapidly adapt forecasts for policy changes (340B reform, IRA implementation, Medicare rebates), incorporating regulatory uncertainty and quantifying financial impacts
- Leverage automation and AI-driven analytics to enhance forecasting accuracy, including predictive modeling, automated variance detection and robust variance analysis methodologies that identify root causes and drive continuous improvement
- Discuss how Finance keeps pace with business changes and adds strategic value by rapidly adapting GTN forecasts to market share gains/losses, product launches and discontinuations and governmental impact on drug pricing, while seamlessly integrating with FP&A and corporate planning cycles to meet strategic targets and enhance shareholder value through proactive scenario planning and cross-functional collaboration
CPE Credits Available: 1.2
- Timothy Bonn - Senior Director, Gross to Net, Breakaway Technologies
- Bal Ram Chopra - Senior Vice President, Finance & Operations, Tethra Biosciences
- Sean McNish - Vice President, Contracts & Pricing, EMD Serono
- Mo Waziri - Head of Pricing, GTN, Allergan Aesthetics, an AbbVie company
- Gain direct insights from auditors on GTN-specific expectations for manufacturers, including documentation standards for rebate accruals, chargeback calculations, Medicaid best price determinations, challenges in estimations of accruals and audit controls, and common GTN compliance gaps that trigger audit findings
- Master best practices for managing auditor relationships throughout GTN audit cycles, from planning rebate provision reviews and fieldwork on revenue recognition to quarter-end closes, provision true-ups and SOX controls specific to gross-to-net calculations
- Understand what auditors prioritize when reviewing GTN work instructions, SOPs for rebate processing, contract interpretation documentation, and control frameworks around price protection mechanisms, with practical guidance on maintaining audit trails for GTN adjustments and supporting evidence for revenue deductions
- Develop proactive approaches to address auditor concerns specific to GTN complexities before they become findings, including effective communication strategies around forecast assumptions, variance explanations for GTN provisions, and relationship management techniques that streamline reviews of complex rebate structures and multi-channel discount programs
CPE Credits Available: 1.2
- Prakash Chainani - Senior Vice President – Finance, HR and IT, Lifestar Pharma LLC (a Mankind Group Company)
- Nick Olivares - Director, Revenue Forecasting & GTN, Lundbeck
- Brett Nussbaum - Head of Gross to Net Accounting, Novartis
- Matt Pellegrini - Former Senior Director - Contract Operations N.A., Formerly Teva Pharmaceuticals
- Master data management fundamentals including traceability, accuracy, governance, and quality controls, with strategies for integrating new data sources such as IRA information and leveraging tools for efficient data validation and scrubbing processes
- Navigate emerging record retention requirements for MFP with clarity on compliance obligations, manage the impact on rebates, and address challenges in payer data submission processes while ensuring cross-source reconciliation and data integrity
- Implement data governance frameworks and organizational structures that establish clear ownership, accountability, and quality standards across GTN data sources, with practical approaches for measuring and improving data quality through KPIs and continuous monitoring
CPE Credits Available: 1.0
- Mike McCarthy - Partner, Argano
- Brian Barbash - Partner, Argano
- Explore emerging trends in organizational structure and design as evolving workflows and technologies prompt companies to reevaluate optimal placement of GTN forecasting, accounting, and contracting functions to maximize efficiency, collaboration, and strategic value in today's dynamic pharmaceutical landscape
- Review comprehensive pharmaceutical industry benchmarking data on current organizational structures, analyzing how GTN teams are positioned within finance, commercial, or hybrid models, and understanding the rationale behind different structural approaches based on company size, portfolios, and strategic priorities
- Identify best practices and industry standards for optimized organizational design, including cross-functional collaboration models, reporting relationships, role definitions, and governance frameworks that enable GTN teams to effectively support business objectives while maintaining compliance, accuracy, and operational excellence in the evolving landscape
CPE Credits Available: 1.0
